People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...

NEW YORK - Oramed Pharmaceuticals Inc . (NASDAQ:ORMP), a clinical-stage pharmaceutical company with a market capitalization of $87 million, has announced the formation of a new joint venture, OraTech ...

The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 ...

The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 ...

The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month period ended December 31, 2024. "Building on our ...

I found this great article on Pet Poison Hotline about Ozempic toxicity in animals. I hope you find this as informative as I did. Administering your pet's medication can often be challenging, ...

Discover how tirzepatide, a diabetes drug, offers hope for congenital generalized lipodystrophy (CGL) treatment, potentially replacing painful daily hormone shots.

In a report released yesterday, Victoria Lambert from Berenberg Bank maintained a Buy rating on Gerresheimer (0NTI – Research Report), with a ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone shots for people with a rare genetic form of lipodystrophy that leaves patients ...

Automated insulin delivery systems have, for the first time, been tested for people with type-one diabetes and end-stage kidney disease. The results found that they were safe and able to offer ...